Item Response Analyses of the Children's Depression Rating Scale-Revised Using Data from Clinical Studies. 2022

Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
Biometrics and Data Management, Pfizer R&D Japan G.K., Shibuya-ku, Tokyo, Japan.

We aimed to identify which of the 17 items comprising the Children's Depression Rating Scale-Revised (CDRS-R) can sensitively capture changes in depression severity. We used data from four studies involving two antidepressants. For each of the 17 CDRS-R items, we conducted item response analyses to identify and evaluate those that reflect changes in depression severity. We created plots of the item characteristic curves (ICCs) estimated by the graded response model, and option characteristic curves and ICCs using nonparametric item response theory. The change from baseline in the CDRS-R subscale score with specified reflective items by item response analyses and the effect size between the treatment group and placebo group were calculated and compared with those of the CDRS-R total score. CDRS-R items #2 (difficulty having fun), #3 (social withdrawal), #10 (low self-esteem), #11 (depressed feelings), and #15 (depressed facial expression) have favorable profiles that reflect disease severity. Changes from baseline in the CDRS-R total score (least square mean ± standard error) at week 8 were -22.3 ± 0.7 and -23.9 ± 0.7 in the placebo group and treatment group, respectively (difference, -1.5; estimated effect size, -0.113), changes from baseline in the CDRS-R5 (CDRS-R subscale consisting of the specified reflective items [#2, #3, #10, #11, and #15]) score at week 8 were -8.4 ± 0.3 and -9.6 ± 0.3 in each group, respectively (difference, -1.2; effect size, -0.202). The item response analyses clarified the properties of 17 items of the CDRS-R for major depressive disorder in children and adolescents. The CDRS-R5 might optimize the assessment of changes in overall depression severity and differentiation of treatment responses.

UI MeSH Term Description Entries
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011594 Psychometrics Assessment of psychological variables by the application of mathematical procedures. Psychometric
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
January 2004, Journal of psychiatric research,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
August 2006, Journal of child and adolescent psychopharmacology,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
December 2010, Journal of child and adolescent psychopharmacology,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
July 2012, Mental illness,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
August 2014, Journal of child and adolescent psychopharmacology,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
January 2005, International journal of adolescent medicine and health,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
May 2018, Journal of child and adolescent psychopharmacology,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
January 1985, Journal of psychiatric research,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
May 1997, Acta psychiatrica Scandinavica,
Hiroki Yoshimatsu, and Takayuki Imaeda, and Tamotsu Yoshiyama, and Shingo Higa, and Keisuke Nomoto
March 1984, Journal of the American Academy of Child Psychiatry,
Copied contents to your clipboard!